Back to stocks
EVMN

EVMN

Evommune, Inc.• Healthcare

Q3 2026 filings are still coming in. 13F filers have 45 days after the quarter ends to report, through November 14, 2026. These totals cover only the funds that have filed so far and will keep rising.
Institutional holders
10
Partial Q3 2026
Total 13F value
$2.1M
Filed positions so far
New positions
4
This quarter
Sold positions
1
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Y-Intercept (Hong Kong) Ltd

$1.3M158.8K0.03%+459.2%

Andera Partners

$804K97.4K0.46%-93.0%

State Of Wyoming

$5K5540.00%-33.9%

Sterling Capital Management Llc

$3K4160.00%+824.4%

Nisa Investment Advisors, Llc

$2K3000.00%+934.5%

Farther Finance Advisors, Llc

$2K2650.00%New Position

Gamma Investing Llc

$2K2310.00%+862.5%

Massmutual Private Wealth & Trust, Fsb

$2K2030.00%New Position

Sjs Investment Consulting Inc.

$166200.00%New Position

Root Financial Partners, Llc

$3340.00%New Position

Explore